Consistent with this observation, our IHC showed that the expression levels of USP5/EphA2 were significantly higher in the radioresistant NPCs than those in the radiosensitive NPCs, indicating that USP5-stabilizing EphA2 might increase clinical NPC radioresistance. This evidence concerns the gene EPHA2 and nasopharyngeal carcinoma.